Skip to main content
Equibles

Caption Management, LLC

Position in PDSB — PDS Biotechnology Corp

CIK 1706766 OKLAHOMA CITY, OK
Back to PDSB Full portfolio

Position in PDSB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record

Derivatives in PDSB

reported options exposure · as of Jun 30, 2026
CallValue
$281,127
CallShares
319,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in PDSB

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $281,127 319,100
2026-03-31 $193,055 319,100
2025-09-30 $221,190 219,000
2025-03-31 $54,145 45,500
2024-12-31 $44,662 27,400
2024-09-30 $105,050 27,500
2024-09-30 $382,000 100,000
2024-06-30 $348,670 119,000
2023-12-31 $40,659 8,181
2023-12-31 $248,500 50,000